Ligand validation:7XMA

PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE

PGV is a Ligand Of Interest in 7XMA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7XMA_PGV_N_607	31%	47%	0.229	0.901	0.94	1.1	2	3	7	0	100%	1
7XMA_PGV_A_607	22%	47%	0.263	0.883	0.94	1.11	2	3	7	0	100%	1
7XMA_PGV_P_303	20%	79%	0.288	0.895	0.33	0.53	-	-	3	0	100%	1
7XMA_PGV_C_301	17%	79%	0.313	0.892	0.37	0.49	-	1	3	0	100%	1
7XMA_PGV_C_305	10%	40%	0.299	0.8	0.96	1.37	2	8	1	0	100%	1
7XMA_PGV_D_201	8%	89%	0.299	0.773	0.32	0.33	-	-	12	0	100%	1
7XMA_PGV_N_609	4%	40%	0.356	0.739	1	1.31	2	7	12	0	100%	1
7XMA_PGV_P_302	3%	40%	0.323	0.661	0.98	1.35	2	8	4	0	100%	1
5B1A_PGV_P_303	98%	35%	0.064	0.985	1.06	1.51	3	13	8	0	100%	1
5X1B_PGV_C_302	95%	52%	0.078	0.981	0.92	0.93	2	4	0	0	100%	1
5B1B_PGV_C_302	94%	56%	0.078	0.979	0.81	0.87	1	1	3	0	100%	1
7YPY_PGV_P_302	94%	54%	0.079	0.978	0.79	0.99	2	2	1	0	100%	1
5ZCQ_PGV_N_608	90%	32%	0.094	0.978	1.15	1.53	5	8	1	0	100%	1
7VUW_PGV_A_608	90%	48%	0.096	0.979	0.89	1.12	2	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.